The management and treatment of hypertension was the topic of this presentation by UPMC's Dr. James Johnson. This presentation was part of UPMC’s Update in Internal Medicine 2010: Evidence-Based Approaches to Common Medical Problems.

Educational Objectives:

Following this course, participants will be able to:

  • Discuss the importance of treating hypertension in order to prevent its consequences
  • Identify the recommended drug treatments, combinations, and sequencing, and some of their results, including the recommended first-line drug for treating hypertension
  • Identify the most important predictor for progression of ESRD and death in hypertension

Faculty Disclosure:

Dr. Johston is a stockholder with Merck, Pfizer, and Baxter.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of .5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to 0.5 hours.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date 4/29/2011 | Review Date 4/29/2011 | Expiration Date 4/28/2012

Title: Hypertension

Faculty: James R. Johnston, MD

Target Audience: nephrologists, general practitioners

Educational Objectives:

Following this course, participants will be able to:

* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension

Faculty Disclosure:

Dr. Johston is a stockholder with Merck, Pfizer, and Baxter.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of .5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to 0.5 hours.

Release Date 4/29/2011 | Review Date 4/29/2011 | Expiration Date 4/28/2012

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.


Title: Hypertension

Faculty: James R. Johnston, MD

Target Audience: nephrologists, general practitioners

Educational Objectives

Following this course, participants will be able to:

* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension

Faculty Disclosure

Dr. Johston is a stockholder with Merck, Pfizer, Amgen, and Baxter.

Accreditation Statement

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME)

to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational

activity for a maximum of .75 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of

their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are

equivalent to 0.75 hours.

Release Date 4/26/2011 | Review Date 4/26/2011 | Expiration Date 4/25/2012

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the

Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME

credit transcript. Providing your SSN is voluntary.

Title: Hypertension

Faculty: James R. Johnston, MD

Target Audience: nephrologists, general practitioners

Educational Objectives

Following this course, participants will be able to:

* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension

Faculty Disclosure

Dr. Johston is a stockholder with Merck, Pfizer, Amgen, and Baxter.

Accreditation Statement

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME)

to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational

activity for a maximum of .75 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of

their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are

equivalent to 0.75 hours.

Release Date 4/26/2011 | Review Date 4/26/2011 | Expiration Date 4/25/2012

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the

Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME

credit transcript. Providing your SSN is voluntary.
This course has been expired.